EFEITOS DA ASSOCIAÇÃO DA IBOGAÍNA E DA AYAHUASCA NA DEPENDÊNCIA ETÍLICA

Fernanda Leticia Dos Santos Matta, Giuliana Facco Machado, Vanessa Martins de Campos, Vivian Frigo Batista, Tamara Veiga Faria, Angelica Possebon, Livia Calixto Batistela Novaes, Isadora Cristina Camargo Cerqueira, Marystela Fávero de Oliveira Cardoso

January 1, 2023 DOI: 10.29327/forumprojetopesqeic2022.496092 via OpenAlex

Relevant Not relevant

Abstract

No abstract available from the source.

Tags

Medicine

Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Psychedelics. • October 28, 2025 • via OpenAlex
Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology Expert Opinion on Drug Discovery • July 4, 2026 • via OpenAlex
Psychedelics and Ibogaine “Pain Medications” at the Pharmacy Counter: Implications for Pharmacy Practice Journal of Pain Research • July 1, 2026 • via OpenAlex
Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive Use Journal of Advances in Developmental Research • June 18, 2026 • via OpenAlex
Indication-stratified mortality risk of ibogaine treatment under contemporary safety protocols: a multisite analysis of 19,071 patients and updated systematic review of fatalities Research Square • June 17, 2026 • via OpenAlex

Comments

No comments yet.

Log in to comment